aluates Reports

$ 0.0

Automative

Global Precision Cancer Diagnostic Tests Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-38D5828

Global Precision Cancer Diagnostic Tests Market Insights Forecast to 2028

BUY CHAPTERS

Global Precision Cancer Diagnostic Tests Market Research Report 2024

Code: QYRE-Auto-38D5828

Report

January 2024

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Precision Cancer Diagnostic Tests Market Size

The global Precision Cancer Diagnostic Tests market was valued at US$ 4148 million in 2023 and is anticipated to reach US$ 9769.5 million by 2030, witnessing a CAGR of 12.5% during the forecast period 2024-2030.

Precision Cancer Diagnostic Tests Market

Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Precision Cancer Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Diagnostic Tests.

Report Scope

The Precision Cancer Diagnostic Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Cancer Diagnostic Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Precision Cancer Diagnostic Tests companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Precision Cancer Diagnostic Tests Market Report

Report Metric	Details
Report Name	Precision Cancer Diagnostic Tests Market
Accounted market size in 2023	US$ 4148 million
Forecasted market size in 2030	US$ 9769.5 million
CAGR	12.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Imaging Molecular Histology/Cytology Tumor Marker Immunoassays POC Colon Cancer Tests
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio-Rad Laboratories, Biocartis N.V., Biocept, bioMerieux SA, Canon Medical Systems Corporation, Cynvenio Biosystems, Danaher Corporation, Epigenomics AG, Exosome Diagnostics, Foundation Medicine, General Electric Company, Genomic Health, Hologic, Illumina, Menarini Silicon Biosystems SpA, Myriad Genetics, NanoString Technologies, Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., Roche Holding AG, Royal Philips N.V., Siemens AG, Thermo Fisher Scientific, Vela Diagnostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Diagnostic Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Precision Cancer Diagnostic Tests Market growing?

Ans: The Precision Cancer Diagnostic Tests Market witnessing a CAGR of 12.5% during the forecast period 2024-2030.

What is the Precision Cancer Diagnostic Tests Market size in 2030?

Ans: The Precision Cancer Diagnostic Tests Market size in 2030 will be US$ 9769.5 million.

Who are the main players in the Precision Cancer Diagnostic Tests Market report?

Ans: The main players in the Precision Cancer Diagnostic Tests Market are Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio-Rad Laboratories, Biocartis N.V., Biocept, bioMerieux SA, Canon Medical Systems Corporation, Cynvenio Biosystems, Danaher Corporation, Epigenomics AG, Exosome Diagnostics, Foundation Medicine, General Electric Company, Genomic Health, Hologic, Illumina, Menarini Silicon Biosystems SpA, Myriad Genetics, NanoString Technologies, Ortho Clinical Diagnostics, QIAGEN N.V., Randox Laboratories Ltd., Roche Holding AG, Royal Philips N.V., Siemens AG, Thermo Fisher Scientific, Vela Diagnostics

What are the Application segmentation covered in the Precision Cancer Diagnostic Tests Market report?

Ans: The Applications covered in the Precision Cancer Diagnostic Tests Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Precision Cancer Diagnostic Tests Market report?

Ans: The Types covered in the Precision Cancer Diagnostic Tests Market report are Imaging, Molecular, Histology/Cytology, Tumor Marker Immunoassays, POC Colon Cancer Tests

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Imaging

1.2.3 Molecular

1.2.4 Histology/Cytology

1.2.5 Tumor Marker Immunoassays

1.2.6 POC Colon Cancer Tests

1.3 Market by Application

1.3.1 Global Precision Cancer Diagnostic Tests Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Precision Cancer Diagnostic Tests Market Perspective (2019-2030)

2.2 Precision Cancer Diagnostic Tests Growth Trends by Region

2.2.1 Global Precision Cancer Diagnostic Tests Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Precision Cancer Diagnostic Tests Historic Market Size by Region (2019-2024)

2.2.3 Precision Cancer Diagnostic Tests Forecasted Market Size by Region (2025-2030)

2.3 Precision Cancer Diagnostic Tests Market Dynamics

2.3.1 Precision Cancer Diagnostic Tests Industry Trends

2.3.2 Precision Cancer Diagnostic Tests Market Drivers

2.3.3 Precision Cancer Diagnostic Tests Market Challenges

2.3.4 Precision Cancer Diagnostic Tests Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue

3.1.1 Global Top Precision Cancer Diagnostic Tests Players by Revenue (2019-2024)

3.1.2 Global Precision Cancer Diagnostic Tests Revenue Market Share by Players (2019-2024)

3.2 Global Precision Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Precision Cancer Diagnostic Tests Revenue

3.4 Global Precision Cancer Diagnostic Tests Market Concentration Ratio

3.4.1 Global Precision Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Diagnostic Tests Revenue in 2023

3.5 Precision Cancer Diagnostic Tests Key Players Head office and Area Served

3.6 Key Players Precision Cancer Diagnostic Tests Product Solution and Service

3.7 Date of Enter into Precision Cancer Diagnostic Tests Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Precision Cancer Diagnostic Tests Breakdown Data by Type

4.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Type (2019-2024)

4.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2025-2030)

5 Precision Cancer Diagnostic Tests Breakdown Data by Application

5.1 Global Precision Cancer Diagnostic Tests Historic Market Size by Application (2019-2024)

5.2 Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Precision Cancer Diagnostic Tests Market Size (2019-2030)

6.2 North America Precision Cancer Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Precision Cancer Diagnostic Tests Market Size by Country (2019-2024)

6.4 North America Precision Cancer Diagnostic Tests Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Precision Cancer Diagnostic Tests Market Size (2019-2030)

7.2 Europe Precision Cancer Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Precision Cancer Diagnostic Tests Market Size by Country (2019-2024)

7.4 Europe Precision Cancer Diagnostic Tests Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Precision Cancer Diagnostic Tests Market Size (2019-2030)

8.2 Asia-Pacific Precision Cancer Diagnostic Tests Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2019-2024)

8.4 Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Precision Cancer Diagnostic Tests Market Size (2019-2030)

9.2 Latin America Precision Cancer Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Precision Cancer Diagnostic Tests Market Size by Country (2019-2024)

9.4 Latin America Precision Cancer Diagnostic Tests Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Precision Cancer Diagnostic Tests Market Size (2019-2030)

10.2 Middle East & Africa Precision Cancer Diagnostic Tests Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2019-2024)

10.4 Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Introduction

11.1.4 Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.1.5 Abbott Laboratories Recent Development

11.2 Agilent Technologies

11.2.1 Agilent Technologies Company Detail

11.2.2 Agilent Technologies Business Overview

11.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Introduction

11.2.4 Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.2.5 Agilent Technologies Recent Development

11.3 Becton Dickinson and Company

11.3.1 Becton Dickinson and Company Company Detail

11.3.2 Becton Dickinson and Company Business Overview

11.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Introduction

11.3.4 Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.3.5 Becton Dickinson and Company Recent Development

11.4 Bio-Rad Laboratories

11.4.1 Bio-Rad Laboratories Company Detail

11.4.2 Bio-Rad Laboratories Business Overview

11.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Introduction

11.4.4 Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.4.5 Bio-Rad Laboratories Recent Development

11.5 Biocartis N.V.

11.5.1 Biocartis N.V. Company Detail

11.5.2 Biocartis N.V. Business Overview

11.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Introduction

11.5.4 Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.5.5 Biocartis N.V. Recent Development

11.6 Biocept

11.6.1 Biocept Company Detail

11.6.2 Biocept Business Overview

11.6.3 Biocept Precision Cancer Diagnostic Tests Introduction

11.6.4 Biocept Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.6.5 Biocept Recent Development

11.7 bioMerieux SA

11.7.1 bioMerieux SA Company Detail

11.7.2 bioMerieux SA Business Overview

11.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Introduction

11.7.4 bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.7.5 bioMerieux SA Recent Development

11.8 Canon Medical Systems Corporation

11.8.1 Canon Medical Systems Corporation Company Detail

11.8.2 Canon Medical Systems Corporation Business Overview

11.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Introduction

11.8.4 Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.8.5 Canon Medical Systems Corporation Recent Development

11.9 Cynvenio Biosystems

11.9.1 Cynvenio Biosystems Company Detail

11.9.2 Cynvenio Biosystems Business Overview

11.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Introduction

11.9.4 Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.9.5 Cynvenio Biosystems Recent Development

11.10 Danaher Corporation

11.10.1 Danaher Corporation Company Detail

11.10.2 Danaher Corporation Business Overview

11.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Introduction

11.10.4 Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.10.5 Danaher Corporation Recent Development

11.11 Epigenomics AG

11.11.1 Epigenomics AG Company Detail

11.11.2 Epigenomics AG Business Overview

11.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Introduction

11.11.4 Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.11.5 Epigenomics AG Recent Development

11.12 Exosome Diagnostics

11.12.1 Exosome Diagnostics Company Detail

11.12.2 Exosome Diagnostics Business Overview

11.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Introduction

11.12.4 Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.12.5 Exosome Diagnostics Recent Development

11.13 Foundation Medicine

11.13.1 Foundation Medicine Company Detail

11.13.2 Foundation Medicine Business Overview

11.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Introduction

11.13.4 Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.13.5 Foundation Medicine Recent Development

11.14 General Electric Company

11.14.1 General Electric Company Company Detail

11.14.2 General Electric Company Business Overview

11.14.3 General Electric Company Precision Cancer Diagnostic Tests Introduction

11.14.4 General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.14.5 General Electric Company Recent Development

11.15 Genomic Health

11.15.1 Genomic Health Company Detail

11.15.2 Genomic Health Business Overview

11.15.3 Genomic Health Precision Cancer Diagnostic Tests Introduction

11.15.4 Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.15.5 Genomic Health Recent Development

11.16 Hologic

11.16.1 Hologic Company Detail

11.16.2 Hologic Business Overview

11.16.3 Hologic Precision Cancer Diagnostic Tests Introduction

11.16.4 Hologic Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.16.5 Hologic Recent Development

11.17 Illumina

11.17.1 Illumina Company Detail

11.17.2 Illumina Business Overview

11.17.3 Illumina Precision Cancer Diagnostic Tests Introduction

11.17.4 Illumina Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.17.5 Illumina Recent Development

11.18 Menarini Silicon Biosystems SpA

11.18.1 Menarini Silicon Biosystems SpA Company Detail

11.18.2 Menarini Silicon Biosystems SpA Business Overview

11.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Introduction

11.18.4 Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.18.5 Menarini Silicon Biosystems SpA Recent Development

11.19 Myriad Genetics

11.19.1 Myriad Genetics Company Detail

11.19.2 Myriad Genetics Business Overview

11.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Introduction

11.19.4 Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.19.5 Myriad Genetics Recent Development

11.20 NanoString Technologies

11.20.1 NanoString Technologies Company Detail

11.20.2 NanoString Technologies Business Overview

11.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Introduction

11.20.4 NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.20.5 NanoString Technologies Recent Development

11.21 Ortho Clinical Diagnostics

11.21.1 Ortho Clinical Diagnostics Company Detail

11.21.2 Ortho Clinical Diagnostics Business Overview

11.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Introduction

11.21.4 Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.21.5 Ortho Clinical Diagnostics Recent Development

11.22 QIAGEN N.V.

11.22.1 QIAGEN N.V. Company Detail

11.22.2 QIAGEN N.V. Business Overview

11.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Introduction

11.22.4 QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.22.5 QIAGEN N.V. Recent Development

11.23 Randox Laboratories Ltd.

11.23.1 Randox Laboratories Ltd. Company Detail

11.23.2 Randox Laboratories Ltd. Business Overview

11.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Introduction

11.23.4 Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.23.5 Randox Laboratories Ltd. Recent Development

11.24 Roche Holding AG

11.24.1 Roche Holding AG Company Detail

11.24.2 Roche Holding AG Business Overview

11.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Introduction

11.24.4 Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.24.5 Roche Holding AG Recent Development

11.25 Royal Philips N.V.

11.25.1 Royal Philips N.V. Company Detail

11.25.2 Royal Philips N.V. Business Overview

11.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Introduction

11.25.4 Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.25.5 Royal Philips N.V. Recent Development

11.26 Siemens AG

11.26.1 Siemens AG Company Detail

11.26.2 Siemens AG Business Overview

11.26.3 Siemens AG Precision Cancer Diagnostic Tests Introduction

11.26.4 Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.26.5 Siemens AG Recent Development

11.27 Thermo Fisher Scientific

11.27.1 Thermo Fisher Scientific Company Detail

11.27.2 Thermo Fisher Scientific Business Overview

11.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Introduction

11.27.4 Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.27.5 Thermo Fisher Scientific Recent Development

11.28 Vela Diagnostics

11.28.1 Vela Diagnostics Company Detail

11.28.2 Vela Diagnostics Business Overview

11.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Introduction

11.28.4 Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024)

11.28.5 Vela Diagnostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Precision Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Imaging

Table 3. Key Players of Molecular

Table 4. Key Players of Histology/Cytology

Table 5. Key Players of Tumor Marker Immunoassays

Table 6. Key Players of POC Colon Cancer Tests

Table 7. Global Precision Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Precision Cancer Diagnostic Tests Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Precision Cancer Diagnostic Tests Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Precision Cancer Diagnostic Tests Market Share by Region (2019-2024)

Table 11. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Precision Cancer Diagnostic Tests Market Share by Region (2025-2030)

Table 13. Precision Cancer Diagnostic Tests Market Trends

Table 14. Precision Cancer Diagnostic Tests Market Drivers

Table 15. Precision Cancer Diagnostic Tests Market Challenges

Table 16. Precision Cancer Diagnostic Tests Market Restraints

Table 17. Global Precision Cancer Diagnostic Tests Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Precision Cancer Diagnostic Tests Market Share by Players (2019-2024)

Table 19. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2023)

Table 20. Ranking of Global Top Precision Cancer Diagnostic Tests Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Precision Cancer Diagnostic Tests Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Precision Cancer Diagnostic Tests Product Solution and Service

Table 24. Date of Enter into Precision Cancer Diagnostic Tests Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Precision Cancer Diagnostic Tests Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2019-2024)

Table 28. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Precision Cancer Diagnostic Tests Revenue Market Share by Type (2025-2030)

Table 30. Global Precision Cancer Diagnostic Tests Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Precision Cancer Diagnostic Tests Revenue Market Share by Application (2019-2024)

Table 32. Global Precision Cancer Diagnostic Tests Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Precision Cancer Diagnostic Tests Revenue Market Share by Application (2025-2030)

Table 34. North America Precision Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Precision Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Precision Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Precision Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Precision Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Precision Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Precision Cancer Diagnostic Tests Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Precision Cancer Diagnostic Tests Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Precision Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Precision Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Precision Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Precision Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Precision Cancer Diagnostic Tests Market Size by Country (2025-2030) & (US$ Million)

Table 49. Abbott Laboratories Company Detail

Table 50. Abbott Laboratories Business Overview

Table 51. Abbott Laboratories Precision Cancer Diagnostic Tests Product

Table 52. Abbott Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 53. Abbott Laboratories Recent Development

Table 54. Agilent Technologies Company Detail

Table 55. Agilent Technologies Business Overview

Table 56. Agilent Technologies Precision Cancer Diagnostic Tests Product

Table 57. Agilent Technologies Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 58. Agilent Technologies Recent Development

Table 59. Becton Dickinson and Company Company Detail

Table 60. Becton Dickinson and Company Business Overview

Table 61. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product

Table 62. Becton Dickinson and Company Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 63. Becton Dickinson and Company Recent Development

Table 64. Bio-Rad Laboratories Company Detail

Table 65. Bio-Rad Laboratories Business Overview

Table 66. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product

Table 67. Bio-Rad Laboratories Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 68. Bio-Rad Laboratories Recent Development

Table 69. Biocartis N.V. Company Detail

Table 70. Biocartis N.V. Business Overview

Table 71. Biocartis N.V. Precision Cancer Diagnostic Tests Product

Table 72. Biocartis N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 73. Biocartis N.V. Recent Development

Table 74. Biocept Company Detail

Table 75. Biocept Business Overview

Table 76. Biocept Precision Cancer Diagnostic Tests Product

Table 77. Biocept Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 78. Biocept Recent Development

Table 79. bioMerieux SA Company Detail

Table 80. bioMerieux SA Business Overview

Table 81. bioMerieux SA Precision Cancer Diagnostic Tests Product

Table 82. bioMerieux SA Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 83. bioMerieux SA Recent Development

Table 84. Canon Medical Systems Corporation Company Detail

Table 85. Canon Medical Systems Corporation Business Overview

Table 86. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product

Table 87. Canon Medical Systems Corporation Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 88. Canon Medical Systems Corporation Recent Development

Table 89. Cynvenio Biosystems Company Detail

Table 90. Cynvenio Biosystems Business Overview

Table 91. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product

Table 92. Cynvenio Biosystems Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 93. Cynvenio Biosystems Recent Development

Table 94. Danaher Corporation Company Detail

Table 95. Danaher Corporation Business Overview

Table 96. Danaher Corporation Precision Cancer Diagnostic Tests Product

Table 97. Danaher Corporation Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 98. Danaher Corporation Recent Development

Table 99. Epigenomics AG Company Detail

Table 100. Epigenomics AG Business Overview

Table 101. Epigenomics AG Precision Cancer Diagnostic Tests Product

Table 102. Epigenomics AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 103. Epigenomics AG Recent Development

Table 104. Exosome Diagnostics Company Detail

Table 105. Exosome Diagnostics Business Overview

Table 106. Exosome Diagnostics Precision Cancer Diagnostic Tests Product

Table 107. Exosome Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 108. Exosome Diagnostics Recent Development

Table 109. Foundation Medicine Company Detail

Table 110. Foundation Medicine Business Overview

Table 111. Foundation Medicine Precision Cancer Diagnostic Tests Product

Table 112. Foundation Medicine Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 113. Foundation Medicine Recent Development

Table 114. General Electric Company Company Detail

Table 115. General Electric Company Business Overview

Table 116. General Electric Company Precision Cancer Diagnostic Tests Product

Table 117. General Electric Company Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 118. General Electric Company Recent Development

Table 119. Genomic Health Company Detail

Table 120. Genomic Health Business Overview

Table 121. Genomic Health Precision Cancer Diagnostic Tests Product

Table 122. Genomic Health Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 123. Genomic Health Recent Development

Table 124. Hologic Company Detail

Table 125. Hologic Business Overview

Table 126. Hologic Precision Cancer Diagnostic Tests Product

Table 127. Hologic Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 128. Hologic Recent Development

Table 129. Illumina Company Detail

Table 130. Illumina Business Overview

Table 131. Illumina Precision Cancer Diagnostic Tests Product

Table 132. Illumina Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 133. Illumina Recent Development

Table 134. Menarini Silicon Biosystems SpA Company Detail

Table 135. Menarini Silicon Biosystems SpA Business Overview

Table 136. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product

Table 137. Menarini Silicon Biosystems SpA Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 138. Menarini Silicon Biosystems SpA Recent Development

Table 139. Myriad Genetics Company Detail

Table 140. Myriad Genetics Business Overview

Table 141. Myriad Genetics Precision Cancer Diagnostic Tests Product

Table 142. Myriad Genetics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 143. Myriad Genetics Recent Development

Table 144. NanoString Technologies Company Detail

Table 145. NanoString Technologies Business Overview

Table 146. NanoString Technologies Precision Cancer Diagnostic Tests Product

Table 147. NanoString Technologies Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 148. NanoString Technologies Recent Development

Table 149. Ortho Clinical Diagnostics Company Detail

Table 150. Ortho Clinical Diagnostics Business Overview

Table 151. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product

Table 152. Ortho Clinical Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 153. Ortho Clinical Diagnostics Recent Development

Table 154. QIAGEN N.V. Company Detail

Table 155. QIAGEN N.V. Business Overview

Table 156. QIAGEN N.V. Precision Cancer Diagnostic Tests Product

Table 157. QIAGEN N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 158. QIAGEN N.V. Recent Development

Table 159. Randox Laboratories Ltd. Company Detail

Table 160. Randox Laboratories Ltd. Business Overview

Table 161. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product

Table 162. Randox Laboratories Ltd. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 163. Randox Laboratories Ltd. Recent Development

Table 164. Roche Holding AG Company Detail

Table 165. Roche Holding AG Business Overview

Table 166. Roche Holding AG Precision Cancer Diagnostic Tests Product

Table 167. Roche Holding AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 168. Roche Holding AG Recent Development

Table 169. Royal Philips N.V. Company Detail

Table 170. Royal Philips N.V. Business Overview

Table 171. Royal Philips N.V. Precision Cancer Diagnostic Tests Product

Table 172. Royal Philips N.V. Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 173. Royal Philips N.V. Recent Development

Table 174. Siemens AG Company Detail

Table 175. Siemens AG Business Overview

Table 176. Siemens AG Precision Cancer Diagnostic Tests Product

Table 177. Siemens AG Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 178. Siemens AG Recent Development

Table 179. Thermo Fisher Scientific Company Detail

Table 180. Thermo Fisher Scientific Business Overview

Table 181. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product

Table 182. Thermo Fisher Scientific Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 183. Thermo Fisher Scientific Recent Development

Table 184. Vela Diagnostics Company Detail

Table 185. Vela Diagnostics Business Overview

Table 186. Vela Diagnostics Precision Cancer Diagnostic Tests Product

Table 187. Vela Diagnostics Revenue in Precision Cancer Diagnostic Tests Business (2019-2024) & (US$ Million)

Table 188. Vela Diagnostics Recent Development

Table 189. Research Programs/Design for This Report

Table 190. Key Data Information from Secondary Sources

Table 191. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Precision Cancer Diagnostic Tests Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Precision Cancer Diagnostic Tests Market Share by Type: 2023 VS 2030

Figure 3. Imaging Features

Figure 4. Molecular Features

Figure 5. Histology/Cytology Features

Figure 6. Tumor Marker Immunoassays Features

Figure 7. POC Colon Cancer Tests Features

Figure 8. Global Precision Cancer Diagnostic Tests Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Precision Cancer Diagnostic Tests Market Share by Application: 2023 VS 2030

Figure 10. Hospital Case Studies

Figure 11. Clinic Case Studies

Figure 12. Other Case Studies

Figure 13. Precision Cancer Diagnostic Tests Report Years Considered

Figure 14. Global Precision Cancer Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Precision Cancer Diagnostic Tests Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Precision Cancer Diagnostic Tests Market Share by Region: 2023 VS 2030

Figure 17. Global Precision Cancer Diagnostic Tests Market Share by Players in 2023

Figure 18. Global Top Precision Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Diagnostic Tests as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2023

Figure 20. North America Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Precision Cancer Diagnostic Tests Market Share by Country (2019-2030)

Figure 22. United States Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Precision Cancer Diagnostic Tests Market Share by Country (2019-2030)

Figure 26. Germany Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Precision Cancer Diagnostic Tests Market Share by Region (2019-2030)

Figure 34. China Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Precision Cancer Diagnostic Tests Market Share by Country (2019-2030)

Figure 42. Mexico Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Precision Cancer Diagnostic Tests Market Share by Country (2019-2030)

Figure 46. Turkey Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Precision Cancer Diagnostic Tests Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Abbott Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 49. Agilent Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 50. Becton Dickinson and Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 51. Bio-Rad Laboratories Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 52. Biocartis N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 53. Biocept Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 54. bioMerieux SA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 55. Canon Medical Systems Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 56. Cynvenio Biosystems Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 57. Danaher Corporation Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 58. Epigenomics AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 59. Exosome Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 60. Foundation Medicine Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 61. General Electric Company Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 62. Genomic Health Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 63. Hologic Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 64. Illumina Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 65. Menarini Silicon Biosystems SpA Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 66. Myriad Genetics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 67. NanoString Technologies Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 68. Ortho Clinical Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 69. QIAGEN N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 70. Randox Laboratories Ltd. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 71. Roche Holding AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 72. Royal Philips N.V. Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 73. Siemens AG Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 74. Thermo Fisher Scientific Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 75. Vela Diagnostics Revenue Growth Rate in Precision Cancer Diagnostic Tests Business (2019-2024)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Precision Medicine Market

AI in Precision Medicine Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Precision Cancer Diagnostic Tests Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-38D5828

Global Precision Cancer Diagnostic Tests Market Research Report 2024

FEATURED COMPANIES

Precision Cancer Diagnostic Tests Market Size

Precision Cancer Diagnostic Tests Market

Report Scope

Scope of Precision Cancer Diagnostic Tests Market Report

Chapter Outline

FAQ for this report

How fast is Precision Cancer Diagnostic Tests Market growing?

What is the Precision Cancer Diagnostic Tests Market size in 2030?

Who are the main players in the Precision Cancer Diagnostic Tests Market report?

What are the Application segmentation covered in the Precision Cancer Diagnostic Tests Market report?

What are the Type segmentation covered in the Precision Cancer Diagnostic Tests Market report?

FEATURED COMPANIES